2026 edition
Top Swiss pharma and biotech brands 2026
The pharmaceutical and biotech brands in the Swiss Lions 100, from global drug makers to contract manufacturers, ranked on global scale, Swiss value creation, visibility and impact.
8 brands in the Swiss Lions 100. Leader: Roche, No. 1 overall.
| 1 |  RocheBasel | No. 1 | CHF 63.0bn | 60 | 69.2 | 50 | 20 | 80.8 |
|---|---|---|---|---|---|---|---|---|
| 2 |  NovartisBasel | No. 4 | CHF 45.8bn | 60 | 70.5 | 50 | 20 | 78.6 |
| 3 |  LonzaBasel | No. 20 | CHF 6.9bn | 60 | 55 | 35 | 20 | 59.5 |
| 4 |  SandozBasel | No. 32 | CHF 7.8bn | 25 | 61.9 | 35 | 20 | 54.5 |
| 5 |  FerringSaint-Prex | No. 49 | CHF 2.4bn e | 60 | 40.8 | 50 | 0 | 48.4 |
| 6 |  SiegfriedZofingen | No. 73 | CHF 1.3bn | 60 | 25.4 | 50 | 0 | 41.8 |
| 7 |  GaldermaZug | No. 81 | CHF 4.0bn | 25 | 48.3 | 0 | 0 | 39.0 |
| 8 |  BachemBubendorf | No. 89 | CHF 709m | 60 | 34.9 | 35 | 0 | 36.1 |
No brand matches. Clear the search or choose All.
Select a column heading to sort, or a brand for its profile. Hover over a heading for its meaning, or over an impact or philanthropy bar for the evidence. e: estimated revenue. GP: gross profit, used for commodity traders.